Know How Meds for Postmenopausal Osteoporosis Stack Up

October 2020

The plethora of med options will raise questions about how to treat postmenopausal osteoporosis...especially with conflicting guidelines.

Which med should be used first? Stick with oral alendronate for most patients. It’s about $60/year...versus $1,700 for risedronate.

If patients can’t take an oral bisphosphonate, try once-yearly IV zoledronic acid (Reclast). It’s about $270/year plus infusion costs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote